(Updated - May 13, 2024 7:37 AM EDT)

Oppenheimer analyst Francois Brisebois lowered the price target on MindMed (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE